•
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in a Series C financing round. The round was led by Kingmed Diagnostics and Guoxin Investment, with contributions from Shenzhen Hi-tech Investment and Venture Capital, Guochuang Zhiyuan, Changzhou Shuangye Venture Capital, and Cai Xin Capital. The…